FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
Status:
Completed
Trial end date:
2012-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide treatment for patients who have chronic lymphocytic
leukemia (CLL), and to compare the use of rituximab added to fludarabine+cyclophosphamide
(FC) with FC alone, to determine if rituximab lengthens the time a patient remains free of
leukemia symptoms.